Research ArticleNeuropharmacology
Dopamine Receptor Agonist Treatment of Idiopathic Dystonia: A Reappraisal in Humans and Mice
Xueliang Fan, Yuping Donsante, H. A. Jinnah and Ellen J. Hess
Journal of Pharmacology and Experimental Therapeutics April 2018, 365 (1) 20-26; DOI: https://doi.org/10.1124/jpet.117.246348
Xueliang Fan
Department of Pharmacology (X.F., Y.D., E.J.H.), Department of Neurology (H.A.J., E.J.H.), and Department of Human Genetics (H.A.J.), School of Medicine, Emory University, Atlanta, Georgia
Yuping Donsante
Department of Pharmacology (X.F., Y.D., E.J.H.), Department of Neurology (H.A.J., E.J.H.), and Department of Human Genetics (H.A.J.), School of Medicine, Emory University, Atlanta, Georgia
H. A. Jinnah
Department of Pharmacology (X.F., Y.D., E.J.H.), Department of Neurology (H.A.J., E.J.H.), and Department of Human Genetics (H.A.J.), School of Medicine, Emory University, Atlanta, Georgia
Ellen J. Hess
Department of Pharmacology (X.F., Y.D., E.J.H.), Department of Neurology (H.A.J., E.J.H.), and Department of Human Genetics (H.A.J.), School of Medicine, Emory University, Atlanta, Georgia

Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleNeuropharmacology
Dopamine Receptor Agonists for the Treatment of Dystonia
Xueliang Fan, Yuping Donsante, H. A. Jinnah and Ellen J. Hess
Journal of Pharmacology and Experimental Therapeutics April 1, 2018, 365 (1) 20-26; DOI: https://doi.org/10.1124/jpet.117.246348
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement